Traders Buy Shares of Monsanto Co. (MON) on Weakness
Traders bought shares of Monsanto Co. (NYSE:MON) on weakness during trading hours on Friday. $71.34 million flowed into the stock on the tick-up and $34.98 million flowed out of the stock on the tick-down, for a money net flow of $36.36 million into the stock. Of all companies tracked, Monsanto had the 8th highest net in-flow for the day. Monsanto traded down ($0.42) for the day and closed at $105.68
A number of research firms have weighed in on MON. Deutsche Bank AG reissued a “buy” rating and set a $100.00 price objective on shares of Monsanto in a research note on Wednesday, June 1st. JPMorgan Chase & Co. reissued a “neutral” rating on shares of Monsanto in a research note on Wednesday, May 25th. TheStreet raised Monsanto to a “buy” rating in a research note on Thursday, May 26th. Vetr raised Monsanto from a “buy” rating to a “strong-buy” rating and set a $123.50 price objective on the stock in a research note on Thursday, May 26th. Finally, Atlantic Securities lowered Monsanto from an “overweight” rating to a “neutral” rating and lowered their price objective for the stock from $109.62 to $105.00 in a research note on Friday, May 27th. Four equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and sixteen have issued a buy rating to the company’s stock. Monsanto currently has an average rating of “Hold” and an average target price of $108.37.
The stock’s 50 day moving average price is $105.40 and its 200 day moving average price is $95.67. The stock has a market capitalization of $46.24 billion and a PE ratio of 46.51.
Monsanto (NYSE:MON) last issued its earnings results on Wednesday, June 29th. The company reported $2.17 earnings per share for the quarter, missing the Zacks’ consensus estimate of $2.40 by $0.23. The company earned $4.19 billion during the quarter, compared to analysts’ expectations of $4.49 billion. During the same quarter in the prior year, the firm earned $2.39 EPS. The company’s revenue was down 8.5% compared to the same quarter last year. Equities analysts anticipate that Monsanto Co. will post $4.46 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 29th. Shareholders of record on Friday, July 8th will be paid a dividend of $0.54 per share. This represents a $2.16 dividend on an annualized basis and a dividend yield of 2.04%. The ex-dividend date is Wednesday, July 6th.
In other Monsanto news, CEO Michael K. Stern sold 12,797 shares of the business’s stock in a transaction dated Wednesday, July 13th. The stock was sold at an average price of $101.77, for a total transaction of $1,302,350.69. Following the transaction, the chief executive officer now owns 21,583 shares in the company, valued at $2,196,501.91. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, COO Brett D. Begemann sold 27,980 shares of the business’s stock in a transaction dated Thursday, July 14th. The stock was sold at an average price of $103.62, for a total value of $2,899,287.60. Following the transaction, the chief operating officer now owns 102,480 shares in the company, valued at approximately $10,618,977.60. The disclosure for this sale can be found here.
Several hedge funds have made changes to their positions in MON. BOKF NA raised its stake in shares of Monsanto by 4.1% in the fourth quarter. BOKF NA now owns 11,203 shares of the company’s stock worth $1,104,000 after buying an additional 441 shares during the last quarter. LS Investment Advisors LLC raised its stake in shares of Monsanto by 3.5% in the fourth quarter. LS Investment Advisors LLC now owns 11,344 shares of the company’s stock worth $1,118,000 after buying an additional 379 shares during the last quarter. Haverford Trust Co. raised its stake in shares of Monsanto by 6.7% in the fourth quarter. Haverford Trust Co. now owns 11,901 shares of the company’s stock worth $1,172,000 after buying an additional 750 shares during the last quarter. Private Advisor Group LLC raised its stake in shares of Monsanto by 5.2% in the fourth quarter. Private Advisor Group LLC now owns 12,082 shares of the company’s stock worth $1,190,000 after buying an additional 592 shares during the last quarter. Finally, Cambridge Investment Research Advisors Inc. raised its stake in shares of Monsanto by 25.3% in the fourth quarter. Cambridge Investment Research Advisors Inc. now owns 16,013 shares of the company’s stock worth $1,578,000 after buying an additional 3,233 shares during the last quarter.
Monsanto Company (Monsanto) is a provider of agricultural products for farmers. The Company’s seeds, biotechnology trait products, and herbicides provide farmers with solutions that improve productivity, reduce the costs of farming, and produce better foods for consumers and better feed for animals. It manages business in two segments: Seeds and Genomics, and Agricultural Productivity.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.